![siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c06455/asset/images/large/ao1c06455_0008.jpeg)
siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega
![Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug | HTML Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-15-00575/article_deploy/html/images/pharmaceuticals-15-00575-g001-550.jpg)
Pharmaceuticals | Free Full-Text | Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug | HTML
![Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease | Cell Death & Disease Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2571-4/MediaObjects/41419_2020_2571_Fig1_HTML.png)
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease | Cell Death & Disease
![Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/66c15db3-b6ea-47e8-9fc0-fee334160941/gr1_lrg.jpg)
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids
![Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms8930/MediaObjects/41467_2015_Article_BFncomms8930_Fig1_HTML.jpg)
Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription | Nature Communications
![Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing - ScienceDirect Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2162253121000846-fx1.jpg)
Advancing peptide siRNA-carrier designs through L/D-amino acid stereochemical modifications to enhance gene silencing - ScienceDirect
![Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/b02d95ef-0731-41d3-9fa5-d84e486c62e4/fx1_lrg.jpg)
Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers: Molecular Therapy - Nucleic Acids
![siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega siRNA Seed Region Is Divided into Two Functionally Different Domains in RNA Interference in Response to 2′-OMe Modifications | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c06455/asset/images/medium/ao1c06455_0002.gif)